Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Seronegative”

Showing 20 of 0 results

Not applicableWithdrawnNCT01059084
What this trial is testing

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons

Who this might be right for
HIVHIV Infections
University of Washington
Early research (Phase 1)Ended earlyNCT04032717
What this trial is testing

Griffithsin-based Rectal Microbicide for PREvention of Viral ENTry (PREVENT)

Who this might be right for
HIV Prevention
Rhonda Brand 18
Early research (Phase 1)Study completedNCT00961883
What this trial is testing

Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults

Who this might be right for
HIV Infections
HIV Vaccine Trials Network 80
Early research (Phase 1)Study completedNCT00002204
What this trial is testing

A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
Chiron Corporation 40
Early research (Phase 1)Study completedNCT00001053
What this trial is testing

A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT00000845
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT02990325
What this trial is testing

A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults

Who this might be right for
HIV InfectionsHealth Volunteers
Abivax S.A. 36
Early research (Phase 1)Study completedNCT00408538
What this trial is testing

Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally

Who this might be right for
HIV Infections
University of California, Los Angeles 36
Not applicableStudy completedNCT01941121
What this trial is testing

CCTG 593: Testing and Linkage to Care

Who this might be right for
HIV PositiveHIV Seronegative
University of California, San Diego 600
Early research (Phase 1)Study completedNCT02346084
What this trial is testing

Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults

Who this might be right for
HIV/AIDS
International Partnership for Microbicides, Inc. 19
Early research (Phase 1)Study completedNCT00000798
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 32
Early research (Phase 1)Study completedNCT00002232
What this trial is testing

GENEVAX-HIV, a Possible Vaccine

Who this might be right for
HIV InfectionsHIV Seronegativity
Wyeth-Lederle Vaccines
Early research (Phase 1)Study completedNCT00441909
What this trial is testing

Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Large-scale testing (Phase 3)Study completedNCT00076232
What this trial is testing

Acyclovir to Help Prevent HIV Infection in People With Genital Herpes

Who this might be right for
HIV InfectionsHIV SeronegativityHerpes Genitalis
National Institute of Allergy and Infectious Diseases (NIAID) 3,682
Early research (Phase 1)Study completedNCT00481182
What this trial is testing

Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.

Who this might be right for
Healthy Subjects
GlaxoSmithKline 20
Early research (Phase 1)Study completedNCT00002428
What this trial is testing

A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects

Who this might be right for
HIV Infections
United Biomedical
Not applicableStudy completedNCT02404805
What this trial is testing

Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers

Who this might be right for
HIVHepatitis C
University of Colorado, Denver 25
Testing effectiveness (Phase 2)Study completedNCT03499795
What this trial is testing

VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2

Who this might be right for
Anal Neoplasm
Inovio Pharmaceuticals 23
Not applicableStudy completedNCT00989144
What this trial is testing

Preliminary Study of Early, Primary HIV Infection in a High Risk Cohort

Who this might be right for
HIV Infections
Thai Red Cross AIDS Research Centre 1,000
Early research (Phase 1)Study completedNCT00000795
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation